- Home
- TSHA vs VEL Comparison
TSHA vs VEL Comparison
Compare TSHA & VEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSHA
- VEL
- Stock Information
- Founded
- TSHA 2019
- VEL 2004
- Country
- TSHA United States
- VEL United States
- Employees
- TSHA N/A
- VEL N/A
- Industry
- TSHA Biotechnology: Pharmaceutical Preparations
- VEL Finance: Consumer Services
- Sector
- TSHA Health Care
- VEL Finance
- Exchange
- TSHA Nasdaq
- VEL Nasdaq
- Market Cap
- TSHA 728.4M
- VEL 680.6M
- IPO Year
- TSHA 2020
- VEL 2020
- Fundamental
- Price
- TSHA $2.32
- VEL $18.69
- Analyst Decision
- TSHA Strong Buy
- VEL Buy
- Analyst Count
- TSHA 5
- VEL 5
- Target Price
- TSHA $8.20
- VEL $21.20
- AVG Volume (30 Days)
- TSHA 3.7M
- VEL 202.3K
- Earning Date
- TSHA 08-11-2025
- VEL 07-31-2025
- Dividend Yield
- TSHA N/A
- VEL N/A
- EPS Growth
- TSHA N/A
- VEL 14.80
- EPS
- TSHA N/A
- VEL 1.94
- Revenue
- TSHA $7,224,000.00
- VEL $177,987,000.00
- Revenue This Year
- TSHA N/A
- VEL N/A
- Revenue Next Year
- TSHA N/A
- VEL $32.82
- P/E Ratio
- TSHA N/A
- VEL $9.55
- Revenue Growth
- TSHA N/A
- VEL 39.36
- 52 Week Low
- TSHA $1.05
- VEL $16.12
- 52 Week High
- TSHA $3.31
- VEL $20.98
- Technical
- Relative Strength Index (RSI)
- TSHA 41.03
- VEL 58.00
- Support Level
- TSHA $2.29
- VEL $18.46
- Resistance Level
- TSHA $2.48
- VEL $19.00
- Average True Range (ATR)
- TSHA 0.17
- VEL 0.42
- MACD
- TSHA -0.05
- VEL -0.04
- Stochastic Oscillator
- TSHA 9.21
- VEL 21.95
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
About VEL Velocity Financial Inc.
Velocity Financial Inc is a United States-based real estate finance company. The company originates and manages investor loans secured by residential rental and small commercial properties. The company earns revenue in the form of interest income. It operates in New York, California, Florida, New Jersey, and other states.